KRAS Inhibitors in Pancreatic Cancer: Hope on the Horizon?

Please enable cookies.

Error
1005

Ray ID: 8c3302cbdca3859b •
2024-09-14 20:08:46 UTC

What happened?

The owner of this website (www.medscape.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website.

Was this page helpful?

Thank you for your feedback!

Cloudflare Ray ID: 8c3302cbdca3859b

Your IP:

185.124.111.116


Performance & security by Cloudflare

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
What If the Doctor Is Out? thumbnail

What If the Doctor Is Out?

Opinion > Second Opinions — Strikes can lead to important changes for interns and residents by Michael Rosenbaum, MD, and Sorcha A. Brophy, PhD September 23, 2023 Rosenbaum is a pediatrician and pediatrics professor. Brophy is an organizational sociologist and professor of health policy & management. Chief Complaint: Los Angeles House Staff Threaten to Strike
Read More
Intervening in Infancy Might Help Prevent Some Cases of Autism thumbnail

Intervening in Infancy Might Help Prevent Some Cases of Autism

By Cara Murez HealthDay ReporterWEDNESDAY, Sept. 22, 2021 (HealthDay News) -- Infants may show early signs of autism, but a diagnosis usually isn't made until age 3. Now, a new study suggests that jumpstarting therapy might stave off that diagnosis altogether.Researchers say their preemptive, parent-led intervention could have a significant impact on children's social development…
Read More
Enfortumab Vedotin Promising in Neovadjuvant Therapy in Advanced Bladder Cancer thumbnail

Enfortumab Vedotin Promising in Neovadjuvant Therapy in Advanced Bladder Cancer

Enfortumab vedotin () appeared to be effective as a neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) who were ineligible for cisplatin-based chemotherapy, according to a small phase Ib/II study. Results from a preliminary analysis of 22 patients showed that eight had a pathologic complete response (pCR, 36.4%, 95% CI 17.2-59.3), displaying no signs…
Read More
Your Kid's Aversion to Broccoli May Be Genetic thumbnail

Your Kid’s Aversion to Broccoli May Be Genetic

By Steven Reinberg HealthDay Reporter THURSDAY, Sept. 23, 2021 (HealthDay News) -- Parents and their children often share numerous traits -- including a dislike for broccoli and other veggies in the same family. Noxious enzymes from bacteria in saliva may be the reason why, a new study suggests. Levels of these compounds are similar in…
Read More
Index Of News
Total
0
Share